DE102009039724A1 - System for non-invasive measurement of blood glucose level of patient, has sensors, where system performs measurement of physicochemical characteristics of glucose related with determination of blood- and/or tissue volumes and tissue water - Google Patents
System for non-invasive measurement of blood glucose level of patient, has sensors, where system performs measurement of physicochemical characteristics of glucose related with determination of blood- and/or tissue volumes and tissue water Download PDFInfo
- Publication number
- DE102009039724A1 DE102009039724A1 DE200910039724 DE102009039724A DE102009039724A1 DE 102009039724 A1 DE102009039724 A1 DE 102009039724A1 DE 200910039724 DE200910039724 DE 200910039724 DE 102009039724 A DE102009039724 A DE 102009039724A DE 102009039724 A1 DE102009039724 A1 DE 102009039724A1
- Authority
- DE
- Germany
- Prior art keywords
- blood
- measurement
- tissue
- determination
- sensors
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
- A61B5/026—Measuring blood flow
- A61B5/0295—Measuring blood flow using plethysmography, i.e. measuring the variations in the volume of a body part as modified by the circulation of blood therethrough, e.g. impedance plethysmography
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/1455—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
- A61B5/6801—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be attached to or worn on the body surface
- A61B5/6813—Specially adapted to be attached to a specific body part
- A61B5/6825—Hand
- A61B5/6826—Finger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
- A61B5/6801—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be attached to or worn on the body surface
- A61B5/683—Means for maintaining contact with the body
- A61B5/6838—Clamps or clips
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/103—Detecting, measuring or recording devices for testing the shape, pattern, colour, size or movement of the body or parts thereof, for diagnostic purposes
- A61B5/107—Measuring physical dimensions, e.g. size of the entire body or parts thereof
- A61B5/1073—Measuring volume, e.g. of limbs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Physics & Mathematics (AREA)
- Medical Informatics (AREA)
- Surgery (AREA)
- Biophysics (AREA)
- Pathology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Optics & Photonics (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Hematology (AREA)
- Cardiology (AREA)
- Physiology (AREA)
- Emergency Medicine (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
Abstract
Description
Das Patent beschreibt ein Verfahren zur nichtinvasiven Blutzuckermessung, das darauf beruht, daß neben der Bestimmung physikochemischer o. ä. Eigenschaften des Blutes gleichzeitig auch gemessen wird, wie groß das gemessene (z. B. durchstrahlte) Volumen ist. Letzteres ändert sich z. B. in der systolischen bzw. diastolischen Phase. Durch Analyse der Bluteigenschaften unter verschiedenen Volumen erhält man Meßwerte, die eine nichtinvasive Blutzuckermessung mit außerordentlich hoher Genauigkeit erlauben.The patent describes a method for non-invasive blood glucose measurement, which is based on the fact that in addition to the determination of physicochemical or similar properties of the blood is also measured at the same time, how large the measured (eg irradiated) volume. The latter changes z. In the systolic or diastolic phase. By analyzing the blood properties under different volumes, measurements are obtained which allow a non-invasive blood glucose measurement with extremely high accuracy.
Die Erfindung bezieht sich auf ein System zur nichtinvasiven Messung des Blutzuckerspiegels, bei dem die genaue Messung durch präzise Bestimmung des verdrängten Volumens an Blut und/oder Gewebswasser erfolgt.The invention relates to a system for the noninvasive measurement of blood sugar level, in which the accurate measurement is carried out by precisely determining the displaced volume of blood and / or tissue water.
Diabetes mellitus ist eine der häufigsten schweren Erkrankungen. Weltweit waren 2007 ca. 250 Millionen Menschen in der Altersgruppe der 20– 79jährigen an Diabetes erkrankt; davon entfallen rd. 50 Millionen auf Europa und rd. 30 Millionen auf die USA. Die Zahl der weltweit Erkrankten wird bis 2025 auf 380 Millionen steigen. Die Kosten werden auf 200 bis 400 Mrd. US$ geschätzt (International Diabetes Federation: Diabetes Atlas, 3. Auflage. Brüssel 2007).Diabetes mellitus is one of the most common serious illnesses. Worldwide in 2007, approximately 250 million people in the age group of 20- to 79-year-olds had diabetes; Of this, approx. 50 million on Europe and approx. 30 million to the US. The number of people worldwide will rise to 380 million by 2025. Costs are estimated at $ 200 to $ 400 billion (International Diabetes Federation: Diabetes Atlas, 3rd edition, Brussels, 2007).
Medizinisch unterscheidet man zwei Typen der Erkrankung: den selteneren Typ I-Diabetes, der in der Jugend einsetzt und auf einer Zerstörung insulinproduzierender Zellen beruht, und den häufigeren Typ II-Diabetes, der eher ältere Patienten betrifft und auf einem relativen Insulinmangel beruht.The medical distinction between two types of disease: the rarer type I diabetes, which is used in adolescence and is based on the destruction of insulin-producing cells, and the more common type II diabetes, which is more likely to elderly patients and based on a relative insulin deficiency.
Unabhängig davon, ob es sich um Typ I oder Typ II handelt, soll der Patient seinen Blutzucker bestimmen. (
Die derzeitigen Messgeräte setzen ausnahmslos voraus, dass der Patient invasiv eine – geringe – Menge Blut entnimmt. (
Für einen anderen Parameter im Blut, nämlich den Anteil des mit Sauerstoff beladenen Hämoglobins, gibt es ein solches Verfahren seit vielen Jahren: die sogenannte Pulsoximetrie (auch Pulsoxymetrie genannt). Sie basiert darauf, dass ein Lichtstrahl durch den Finger des Patienten geschickt und auf der anderen Seite gemessen wird, wie viel von dem Licht absorbiert wurde. Da sauerstoffarmes bzw. sauerstoffgesättigtes Hämoglobin unterschiedliche Absorptionsspektren haben, kann man daraus die Konzentrationen bestimmen. (Eine detaillierte Beschreibung findet sich z.
Das Verfahren der Pulsoximetrie benutzt neben der Messung der Lichtabsorption ein weiteres Verfahren, das im Prinzip auch für die Blutzuckermessung anwendbar ist: es misst die Absorption zu verschiedenen Zeitpunkten einer Pulswelle. Da während der systolischen Phase die Blutgefäße mit mehr Blut gefüllt sind als in der diastolischen, kann man darauf schließen, wie viel Lichtabsorption auf das Gewebe entfällt und wie viel auf das Blut. Statt die Pulswelle passiv zu registrieren, kann man natürlich auch die Durchblutung beeinflussen, z. B., indem man – wie bei der Blutdruckmessung – eine Manschette auf übersystolischen Druck aufbläst, worauf die Durchblutung vorübergehend stoppt.The method of pulse oximetry uses, in addition to the measurement of light absorption, another method that is also applicable in principle for the blood sugar measurement: it measures the absorption at different times of a pulse wave. Since during the systolic phase, the blood vessels are filled with more blood than in the diastolic, one can conclude how much light absorption is due to the tissue and how much on the blood. Instead of passively registering the pulse wave, one can of course also influence the blood circulation, z. For example, by inflating a cuff to over-systolic pressure, as in blood pressure measurement, and then temporarily stopping blood flow.
Bei Laborversuchen ist es seit vielen Jahren gelungen, die Zuckerkonzentration einer Lösung mit Methoden der Lichtabsorption zu messen. (Z. B.
Daher liegt der Versuch nahe, die Prinzipien der Pulsoximetrie, nämlich die Messung der Absorption oder einer anderen spezifischen Eigenschaft und das Verhalten einer Pulswelle auf die Messung der Glucose zu übertragen. Solche Vorhaben sind in dem o. g. Buch von Tuchin beschrieben. Vielfach wurden sie auch zum Patent angemeldet, z. B. bereits 1997 als
Allerdings ist es bisher nicht gelungen, diese Laborversuche in die medizinische Praxis umzusetzen. Das Hauptproblem, das bisher ungelöst war und mit der vorliegenden Erfindung gelöst wird, besteht darin, dass das Verhältnis zwischen dem Signal der Glucose, z. B. seiner spezifischen Absorption, sehr gering ist im Verhältnis aller übrigen Substanzen, Gewebe usw., die ebenfalls Licht absorbieren. Das liegt wiederum v. a. an der im Verhältnis zum Hämoglobin sehr geringen Lichtabsorption der Glucose. Trotz ausgefeilter statistischer Verfahren ist es bisher nicht gelungen, die Glucosekonzentration aus dem Grundrauschen der übrigen Lichtabsorber mit hinreichender Genauigkeit herauszurechnen.However, so far it has not been successful, these laboratory experiments in medical practice implement. The main problem that has been unresolved and solved by the present invention is that the ratio between the signal of glucose, e.g. B. its specific absorption, is very low in the ratio of all other substances, tissues, etc., which also absorb light. This, in turn, is mainly due to the very low light absorption of glucose in relation to hemoglobin. Despite sophisticated statistical methods, it has not yet been possible to calculate the glucose concentration from the background noise of the other light absorbers with sufficient accuracy.
Die Erfindung löst das Problem, indem sie die Messdaten durch Einführung einer weiteren Messgrösse präzisiert, nämlich durch die präzise Bestimmung des gemessenen Blutvolumens.The invention solves the problem by specifying the measured data by introducing a further measured variable, namely by the precise determination of the measured blood volume.
In der einfachsten Version besteht das System aus einem Messgerät, das eine physikochemische Eigenschaft der Glucose nutzt, z. B. ihre Absorption, einem Sensor, der das untersuchte Blutvolumen misst, und einem Computer.In the simplest version, the system consists of a measuring device that uses a physicochemical property of glucose, eg. Their absorption, a sensor that measures the volume of blood being examined, and a computer.
Im Rahmen der Durchblutung verändert sich der Durchmesser des Fingers. Im gleichen Rhythmus verändern die Lichtquelle
ZITATE ENTHALTEN IN DER BESCHREIBUNG QUOTES INCLUDE IN THE DESCRIPTION
Diese Liste der vom Anmelder aufgeführten Dokumente wurde automatisiert erzeugt und ist ausschließlich zur besseren Information des Lesers aufgenommen. Die Liste ist nicht Bestandteil der deutschen Patent- bzw. Gebrauchsmusteranmeldung. Das DPMA übernimmt keinerlei Haftung für etwaige Fehler oder Auslassungen.This list of the documents listed by the applicant has been generated automatically and is included solely for the better information of the reader. The list is not part of the German patent or utility model application. The DPMA assumes no liability for any errors or omissions.
Zitierte PatentliteraturCited patent literature
- US 5638816 [0010] US 5638816 [0010]
- US 6993372 [0010] US 6993372 [0010]
Zitierte Nicht-PatentliteraturCited non-patent literature
- Renz-Polster, H., Krautzig, S.: Basislehrbuch Innere Medizin. München 2008, S. 868 [0005] Renz-Polster, H., Krautzig, S .: Basic textbook Internal Medicine. Munich 2008, p. 868 [0005]
- Fragkou, V., Turner, A. P. F.: Commercial Biosensors for Diabetes. In: Tuchin, V. V. (ed.): Handbook of optical sensing of glucose in biological fluids and tissues. Boca Raton, FL 2009 [0006] Fragkou, V., Turner, APF: Commercial Biosensors for Diabetes. In: Tuchin, VV (ed.): Handbook of optical sensing of glucose in biological fluids and tissues. Boca Raton, FL 2009 [0006]
- B. in: Webster, J. G.: Design of Pulse Oximeters. Bristol 1997 [0007] Webster, JG: Design of Pulse Oximeters. Bristol 1997 [0007]
- Müller, A.: Blutzuckermessungen ohne Verletzungen. Vallendar 1994 [0009] Müller, A .: Blood sugar measurements without injuries. Vallendar 1994 [0009]
- Kondepati, V. R. und Heise, H. M.: Recent Progress in analytical instrumentation for glycemic control in diabetic and critically ill patients. Anal Bioanal Chem (2007) 388: 545–563 [0009] Kondepati, VR and Heise, HM: Recent progress in analytical instrumentation for glycemic control in diabetic and critically ill patients. Anal Bioanal Chem (2007) 388: 545-563 [0009]
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE200910039724 DE102009039724A1 (en) | 2009-08-28 | 2009-08-28 | System for non-invasive measurement of blood glucose level of patient, has sensors, where system performs measurement of physicochemical characteristics of glucose related with determination of blood- and/or tissue volumes and tissue water |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE200910039724 DE102009039724A1 (en) | 2009-08-28 | 2009-08-28 | System for non-invasive measurement of blood glucose level of patient, has sensors, where system performs measurement of physicochemical characteristics of glucose related with determination of blood- and/or tissue volumes and tissue water |
Publications (1)
Publication Number | Publication Date |
---|---|
DE102009039724A1 true DE102009039724A1 (en) | 2011-03-03 |
Family
ID=43525205
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE200910039724 Withdrawn DE102009039724A1 (en) | 2009-08-28 | 2009-08-28 | System for non-invasive measurement of blood glucose level of patient, has sensors, where system performs measurement of physicochemical characteristics of glucose related with determination of blood- and/or tissue volumes and tissue water |
Country Status (1)
Country | Link |
---|---|
DE (1) | DE102009039724A1 (en) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5638816A (en) | 1995-06-07 | 1997-06-17 | Masimo Corporation | Active pulse blood constituent monitoring |
US6993372B2 (en) | 2003-06-03 | 2006-01-31 | Orsense Ltd. | Method and system for use in non-invasive optical measurements of blood parameters |
-
2009
- 2009-08-28 DE DE200910039724 patent/DE102009039724A1/en not_active Withdrawn
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5638816A (en) | 1995-06-07 | 1997-06-17 | Masimo Corporation | Active pulse blood constituent monitoring |
US6993372B2 (en) | 2003-06-03 | 2006-01-31 | Orsense Ltd. | Method and system for use in non-invasive optical measurements of blood parameters |
Non-Patent Citations (5)
Title |
---|
B. in: Webster, J. G.: Design of Pulse Oximeters. Bristol 1997 |
Fragkou, V., Turner, A. P. F.: Commercial Biosensors for Diabetes. In: Tuchin, V. V. (ed.): Handbook of optical sensing of glucose in biological fluids and tissues. Boca Raton, FL 2009 |
Kondepati, V. R. und Heise, H. M.: Recent Progress in analytical instrumentation for glycemic control in diabetic and critically ill patients. Anal Bioanal Chem (2007) 388: 545-563 |
Müller, A.: Blutzuckermessungen ohne Verletzungen. Vallendar 1994 |
Renz-Polster, H., Krautzig, S.: Basislehrbuch Innere Medizin. München 2008, S. 868 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE19518511C2 (en) | Method for the transcutaneous, bloodless determination of the concentration of substances in blood in vivo | |
EP0589862B1 (en) | Sensor device | |
DE60223787T2 (en) | METHOD AND DEVICE FOR IMPROVING THE ACCURACY OF NONINVASIVE HEMATOCRIT MEASUREMENTS | |
EP0567447B1 (en) | Sensor arrangement for the direct or indirect determination of the physical or chemical parameter | |
EP2203114B1 (en) | Medical measuring device for bioelectrical impedance measurement | |
DE60318323T2 (en) | CALIBRATION TECHNOLOGY FOR NON-INVASIVE MEDICAL DEVICES | |
DE60031551T2 (en) | DEVICE FOR VERIFYING THE ACCURACY OF A SPECTRAL ANALYZER | |
JP2003245266A (en) | Highly reliable noninvasive blood gas measuring method | |
JP2009519765A (en) | IN-VIVO non-invasive bioelectrical impedance analysis of glucose-mediated changes in tissues | |
DE102005057757A1 (en) | Integrated-type physiological signal evaluation apparatus for measuring cardiovascular parameters, has detection interface modules having two electrodes for obtaining electrocardiogram signal of subject | |
DE19512478A1 (en) | Calibration of blood gas analysis sensors | |
DE19923658A1 (en) | Device for measuring organization grade of water in mammals for diagnosis of disease conditions | |
DE102009039724A1 (en) | System for non-invasive measurement of blood glucose level of patient, has sensors, where system performs measurement of physicochemical characteristics of glucose related with determination of blood- and/or tissue volumes and tissue water | |
EP2757942A1 (en) | Diagnostic measurement device | |
DE202007019341U1 (en) | Device for non-invasive measurement of blood sugar | |
AT501013B1 (en) | DEVICE AND METHOD FOR MEASURING INDICATOR CONCENTRATION AND APPARATECLEARANCE IN EXTRACORPORAL BLOOD TREATMENT PROCEDURES | |
DE102009039054A1 (en) | System for non-invasive measurement of blood sugar level of patient during diagnosis of diabetes mellitus, has control circuit for evaluating data e.g. glucose concentration, and controlling volume of blood by exerting pressure on tissue | |
DE102013222123A1 (en) | Mobile monitoring device | |
DE102006026126A1 (en) | Fractional oxygen saturation monitoring and pathological changes detection method for patient`s cardiovascular circulation system, involves evaluating photoplethysmogram signals, and deriving parameters interpreted for doctor from signals | |
DE102008022919A1 (en) | Device for optimized pulse measurement of heart of person during e.g. medical diagnosis, has detector for detecting light reemitted from skin tissue, and emitter emitting light with wavelength in given range of specific Newton meter | |
DE19609387C2 (en) | Blood glucose meter | |
DE19751564B4 (en) | blood pressure measuring device | |
DE3108767C2 (en) | Medical blood pressure transducer | |
DE102006025005B4 (en) | Device for determining the blood oxygen content | |
AT509964B1 (en) | DEVICE AND METHOD FOR DETERMINING A FERTILIZED PHASE OF A WOMAN BY DETERMINING A CO2 PARTIAL PRESSURE IN A WOMAN'S GAS |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
R119 | Application deemed withdrawn, or ip right lapsed, due to non-payment of renewal fee | ||
R119 | Application deemed withdrawn, or ip right lapsed, due to non-payment of renewal fee |
Effective date: 20150303 |